Ativan
NDC Package 60977-113-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ativan is a medication used to treat serious seizures that do not stop (status epilepticus). Marketed by Baxter Healthcare Corporation, this product is identified by NDC 60977-113 and is authorized under FDA application NDA018140.

Identification & Billing

NDC Package Code
60977-113-01
Package Description
25 VIAL in 1 PACKAGE / 1 mL in 1 VIAL (60977-113-81)
Product Code
11-Digit Billing Format
60977011301

Clinical Specifications

Proprietary Name
Ativan
Dosage Form
-
Usage Information
This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.

Regulatory & Marketing

Labeler Name
Baxter Healthcare Corporation
FDA Application #
NDA018140
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-24-2009
End Marketing Date
01-31-2014
Listing Expiration
01-31-2014
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (60977-113). Click a package code to view its specific billing and regulatory data.

10 VIAL in 1 PACKAGE / 10 mL in 1 VIAL (60977-113-71)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60977-113-01 identifies a specific commercial package of 25 vial in 1 package / 1 ml in 1 vial (60977-113-81) of Ativan, labeled by Baxter Healthcare Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Baxter Healthcare Corporation on September 24, 2009. The current certification is valid through January 31, 2014.

What are the primary indications for this medication?

This medication is used to treat serious seizures that do not stop (status epilepticus). It is also used before surgeries or procedures to cause drowsiness, decrease anxiety, and cause forgetfulness about the procedure or surgery. Lorazepam belongs to a class of medications called benzodiazepines, which produce a calming effect on the brain and nerves (central nervous system). It is thought to work by increasing the effect of a certain natural chemical (GABA) in the brain.

How is this Baxter Healthcare Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60977011301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60977-113-01
11-Digit CMS (5-4-2)
60977-0113-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.